Raevti Bole, MD

Appointed
2022

Education & Fellowships

Fellowship - Cleveland Clinic Foundation
Urology/Male Infertility
Cleveland, OH
2023

Residency - Mayo Clinic
Urology
Rochester, MN
2022

Internship - Mayo Clinic
General Surgery
Rochester, MN United States
2017

Medical Education - University of Kentucky College of Medicine
Lexington, KY United States
2016

Graduate School - Columbia University
Biotechnology
New York, NY
2012

Undergraduate - University of Toronto
Immunology/Human Biology
CANADA, ON Canada
2011

Professional Highlights

• In addition to her clinical work, Dr. Bole holds leadership roles in professional organizations. These include co-Chair of the Social Media Committee for the Society for the Study of Male Reproduction and member of the Educational Projects Committee and Young Clinicians Committee for the Sexual Medicine Society of North America. Dr. Bole also serves as a peer reviewer for several medical journals, including Urology, Fertility & Sterility, International Journal of Impotence Research, and Translational Andrology and Urology.

Certifications

• Urology

Awards & Honors

• Dr. Bole has been recognized for her outstanding contributions and achievements. She received the Velosano Pilot Research Grant in 2023 as a co-investigator, and in 2022, she was awarded the SMSNA Fellowship Training Grant for Women in Prosthetic Urology. She has also received multiple other honors, including the 18th Annual Joseph W. Segura Essay Contest (3rd place, 2022), the SMSNA Best Essay Prize (2021), and the SMRU Lipschultz/Lamb Traveling Scholar Award (2021). Dr. Bole has published numerous articles in scientific journals and presented her research at various conferences and has received awards for her work in male infertility.

See publications for Raevti Bole, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 10/1/2024, Dr. Bole has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.